Abstract
Studies in preterm infants have shown an association between late-onset sepsis (LOS) and the development of bronchopulmonary dysplasia (BPD). It is unknown whether clinical or biochemical characteristics during sepsis modulate the risk for BPD. This single-center retrospective cohort study included all patients with a gestational age < 30 weeks, born between 2009 and 2015, in whom empiric antimicrobial treatment was initiated > 72 h after birth and continued for at least 5 days, independent on microbiological results. The association between clinical and biochemical characteristics of LOS and the development of BPD in survivors were assessed with multivariate logistic regression analysis adjusted for early-onset sepsis, small for gestational age, and gestational age. Of the 756 admitted infants, 256 infants (mean GA: 27.0 weeks; birthweight: 924 grams) had at least one LOS episode, of whom 79 (30.9%) developed BPD. Analyses showed that only the need for and duration of mechanical ventilation during LOS were independently associated with an increased risk for BPD (adjusted OR 2.62, 95% CI 1.38, 4.96, p value 0.003, and OR 1.004, 95% CI 1.00, 1.007, p value 0.045, respectively).
Conclusion: During a LOS, the need for and duration of mechanical ventilation are independently associated with the risk of developing BPD in preterm infants.
|
What is Known: • Premature infants diagnosed with a late-onset sepsis are at higher risk of developing bronchopulmonary dysplasia • This association is mainly shown in infants with a positive blood culture | |
|
What is New: • This study investigates the clinical and biochemical characteristics of late-onset sepsis and the development of bronchopulmonary dysplasia • The need for mechanical ventilation and duration of mechanical ventilation during late-onset sepsis are associated with an increased risk of developing bronchopulmonary dysplasia. |
Supplementary Information
The online version contains supplementary material available at 10.1007/s00431-021-03981-9.
Keywords: Premature infants, Late-onset sepsis, Bronchopulmonary dysplasia
Introduction
Bronchopulmonary dysplasia (BPD) remains the most common complication in extremely preterm born infants [1, 2]. While the pathogenesis is multifactorial and complex, inflammation plays a central role in the development of BPD [3, 4]. Systemic inflammation due to neonatal sepsis interacts with lung development causing underdeveloped alveoli and dysmorphic pulmonary vasculature, which are the histological hallmarks of BPD [5–8]. The association between sepsis and the risk for developing BPD is well established [5, 9, 10]. Observational studies have shown that both early-onset neonatal sepsis (EOS; < 72 h after birth) and late-onset neonatal sepsis (LOS; ≥ 72 h after birth) are associated with an increased risk for mortality and BPD [9–13]. However, most of these studies only included infants with culture-proven sepsis, while a negative blood culture does not exclude sepsis in this population [14–16]. Furthermore, these studies did not consider the fact that sepsis is a complex systemic disease with distinct differences in causative microorganism, age at onset, and clinical or biochemical characteristics. To date it remains unclear if and how these differences impact the association between sepsis and BPD. Unraveling which sepsis characteristics are independently associated with the development of BPD might improve our ability to identify those patient most at risk for developing BPD and target treatment to this specific population.
To address the abovementioned knowledge gaps, the current study collected data on the characteristics of sepsis and the diagnosis BPD in a population of preterm infants treated with antibiotics for clinical or culture-proven sepsis. Given the difference in incidence and clinical/biochemical characteristics between early and late-onset sepsis, we focused in this study on episodes of LOS [17]. The aim of this study is to investigate if the development of BPD is associated with one or more clinical and/or biochemical characteristics of sepsis.
Materials and methods
Study design, setting, and participants
This retrospective observational cohort study included preterm infants below 30 weeks of gestation who were admitted within 24 h after birth to the Neonatal Intensive Care Unit (NICU) of the Amsterdam University Medical Centers, between January 1, 2009, and December 31, 2015. Infants were eligible if empiric antimicrobial treatment was initiated ≥ 72 h after birth and continued for at least 5 days independent of microbiological results. For parental consent, an opt-out procedure was followed, and this study was approved by the institutional review board.
Data collection
The following characteristics and outcomes were collected for each patient: sex; gestational age (GA); birthweight (BW); small for gestational age (SGA) defined as BW below the 10th percentile [18]; outborn; singleton birth; administration of antenatal steroids; mode of delivery; premature rupture of the membranes; Apgar score at 5 min; mode and duration of respiratory support in the delivery room and NICU; ventilation free days during admission; base FiO2 and respiratory support before LOS episode; treatment with exogenous surfactant; and caffeine and dexamethasone.
Early-onset sepsis (EOS) was defined as an infectious episode starting within 72 h after birth for which antibiotic treatment was given for 5 days or more. Late-onset sepsis (LOS) was defined as an episode with clinical signs and symptoms suspected for sepsis starting ≥ 72 h after birth for which empiric antimicrobial treatment was initiated and continued for at least 5 days independent of microbiological results. In this group, we also included infants with NEC ≥ grade 2, since the majority of these patients has a culture-proven or a clinical-suspected sepsis episode [19].
For every episode of LOS, the following data were collected: postnatal age of first administration of antibiotics, divided in 3–7 days, 7–14 days, and > 14 days after birth; the number of LOS episodes; type of microorganism; c-reactive protein (CRP); white blood cell count; use of cardiotonics (dopamin, dobutamin, epinephrine, or norepinephrine); and need for and duration of mechanical ventilation during LOS episode.
The primary outcome of this study was moderate or severe BPD defined as the need for supplemental oxygen for at least 28 days and the need for ≥ 30% supplemental oxygen or positive pressure ventilation at 36-week postmenstrual age (PMA) [20].
Data analysis
Statistical analysis was performed with IBM SPSS Statistics for Windows, version 24 (IBM Corp., Armonk, NY, USA). Data were expressed as mean with standard deviation (SD) or median with interquartile range (IQR) depending on their distribution. Patients with missing BPD diagnoses and those infants who died before 36 weeks PMA were excluded from the analyses. Whole case analysis was performed. Patient characteristics were compared between infants with and without BPD with univariate analyses, e.g., Chi square-tests for dichotomous data and independent samples t tests for continuous data or their nonparametric equivalents.
To explore the association between LOS-associated factor, such as the postnatal age of first administration of antibiotics, number of LOS episodes, laboratory findings, medication use and mechanical ventilation, and the incidence of BPD, logistic regression analyses were performed. In case of multiple LOS episodes, the LOS-associated factors of the most severe infectious episode were used, defined as the episode with most of the following conditions present: an elevated CRP > 45 mg/L [21], leukopenia (defined as < 4 × 10^9/L) or leukocytosis (defined as > 20 × 10^9/L) [22], use of cardiotonics, and need for mechanical ventilation. A multivariate regression model was performed to investigate whether this association was influenced by EOS, GA, and SGA since these factors considered as independent risk factors for a LOS episode [9, 23]. To assess model fit, the Hosmer-Lemeshow goodness-of-fit test was performed.
Two sensitivity analyses were performed to test the robustness of possible associations between LOS characteristics and BPD. First, we assessed the impact of having a positive blood culture, by excluding infants with culture negative sepsis. Second, we assessed the impact of having multiple episodes of LOS by including only infants enduring one LOS episode. Data were expressed as odds ratios (OR) and 95% confidence interval (CI). A p value of < 0.05 was considered statistical significant.
Results
Patient characteristics
Of the 756 infants admitted during the study period, 256 (33.8%) infants were diagnosed with one or more LOS episode during hospitalization. Compared to the infants without LOS, the infants with LOS had lower BW, GA, and a higher incidence of all major morbidities such as PDA, NEC, and BPD (Supplemental Table 1). BPD diagnosis could not be retrieved in 4 cases (1.5%). Forty three (16.7%) of the infants with one or more LOS episodes died before 36 weeks PMA (Fig. 1). Therefore, the final cohort of interest consisted of 209 infants, of whom 79 (37.8%) developed moderate to severe BPD at 36 weeks PMA. The patient characteristics of the survivors with or without BPD are summarized in Table 1. Compared to the infants without BPD, the infants diagnosed with BPD had a lower GA, BW, longer duration of (non-)invasive respiratory support, and were more often treated with surfactant, and dexamethasone.
Fig. 1.
Flow chart. LOS: late onset sepsis. PMA: postmenstrual age. BPD: Bronchopulmonary dysplasia. NEC: Necrotizing enterocolitis.
Table 1.
Patient characteristics of preterm survivors with and without BPD at 36-week postmenstrual age
| Characteristics | BPD n = 79 |
No BPD n = 130 |
p value |
|---|---|---|---|
| Gender, male—no. (%) | 49 (62.0%) | 65 (50.0%) | 0.90 |
| Gestational age—wk median/IQR | 26.7 (25.7, 27.9) | 27.6 (26.1, 28.9) | < 0.001 |
| Birth weight—g mean/SD | 861 (200) | 983 (263) | < 0.001 |
| Small for gestational age—no. (%) | 19 (24.1%) | 18 (13.8%) | 0.06 |
| Outborn—no. (%) | 6 (7.6%) | 10 (7.7%) | 0.98 |
| Singleton—no. (%) | 58 (73.4%) | 94 (72.3%) | 0.86 |
| Antenatal corticosteroids—no. (%) | 74 (93.7%) | 120 (92.3%) | 0.71 |
| Cesarean section—no. (%) | 34 (43.0%) | 61 (46.9%) | 0.58 |
| PPROM—no. (%) | 18 (22.8%) | 25 (19.2%) | 0.54 |
| Apgar score at 5 min median/IQR | 8 (6, 9) | 8 (7, 9) | 0.51 |
| EOS—no. (%) | 27 (34.2%) | 31 (23.8%) | 0.11 |
| Intubation at delivery room—no. (%) | 12 (15.2%) | 11 (8.5%) | 0.43 |
| Mechanical ventilation during admission—no. (%) | 71 (89.9%) | 95 (73.1%) | < 0.001 |
| Mechanical ventilation (days) median/IQR | 8.3 (2.9, 16.3) | 2.6 (1.4, 6.1) | < 0.001 |
| CPAP (days) median/IQR | 40.5 (32.4, 46.0) | 27.8 (13.1, 39.0) | < 0.001 |
| Ventilation free during admission (days) mean/SD | 58.6 (23.9) | 39.3 (17.0) | < 0.001 |
| Base FiO2 before mechanical ventilation during LOS—median/IQR | 0.37 (0.26, 0.55) | 0.25 (0.21, 0.51) | 0.30 |
| Respiratory support before mechanical ventilation during LOS | |||
| High flow—no. (%) | 0 (0.0%) | 6 (9.1%) | |
| CPAP—no. (%) | 43 (74.1%) | 42 (63.6%) | 0.09 |
| nIMV—no. (%) | 15 (25.9%) | 12 (18.2%) | |
| Surfactant—no. (%) | 48 (60.8%) | 55 (42.3%) | 0.01 |
| Caffeine—no. (%) | 78 (98.7%) | 128 (98.5%) | 0.87 |
| Dexamethasone—no. (%) | 19 (24.1%) | 10 (7.7%) | < 0.001 |
PPROM preterm premature rupture of membranes, EOS early-onset sepsis, CPAP continuous positive airway pressure. IQR interquartile range, no number, SD standard deviation
Outcome
The need for and duration of mechanical ventilation during LOS are higher in the group of infants developing BPD, compared to the group of infants without BPD (OR 3.22, 95% CI 1.76, 5.91, p value < 0.001, and OR 1.004, 95% CI 1.001, 1.007, p value 0.023) (Table 2). The postnatal age of LOS onset, the number of LOS episodes, the type of microorganism found in the blood culture, a CRP value > 45 mg/L [21], leukocytosis or leukopenia, and use of cardiotonics were not different in the BPD versus no BPD group. The multivariate logistic regression analysis correcting for EOS, GA, and SGA showed that only the need for and duration of mechanical ventilation during LOS were independently associated with an increased risk for BPD (adjusted OR 2.62, 95% CI 1.38, 4.96, p value 0.003, and OR 1.004, 95% CI 1.00, 1.007, p value 0.045).
Table 2.
Late-onset sepsis characteristics in preterm survivors with and without BPD at 36-week postmenstrual age
| Infants with LOS | BPD N = 79 | No BPD N = 130 |
OR | 95% CI | p value | aORa | 95% CIa | p valuea | Hosmer-Lemeshow |
|---|---|---|---|---|---|---|---|---|---|
| Postnatal age 1st LOS onset | |||||||||
| < 7 days—no. (%) | 22 (27.8%) | 43 (33.1%) | 0.78 | (0.42, 1.44) | 0.43 | 0.83 | (0.42, 1.62) | 0.58 | ns |
| 7–14 days—no. (%) | 33 (41.8%) | 59 (45.4%) | 0.86 | (0.49, 1.52) | 0.61 | 0.87 | (0.48, 1.58) | 0.65 | ns |
| ≥ 14 days—no.(%) | 24 (30.4%) | 28 (21.5%) | 1.59 | (0.84, 3.00) | 0.15 | 1.45 | (0.74, 2.84) | 0.28 | ns |
| > 1 episode of LOS—no. (%) | 28 (35.4%) | 32 (24.6%) | 1.68 | (0.91, 3.09) | 0.095 | 1.27 | (0.65, 2.48) | 0.49 | 0.030 |
| Positive blood culture—no.(%) | 59 (74.7%) | 100 (76.9%) | 0.89 | (0.46, 1.70) | 0.71 | 0.95 | (0.48, 1.87) | 0.88 | ns |
| Gram stained bacteria | |||||||||
| Gram pos—no. (%) | 24 (30.4%) | 40 (30.8%) | 0.98 | (0.54, 1.80) | 0.95 | 0.82 | (0.43, 1.57) | 0.55 | ns |
| Gram neg—no. (%) | 21 (26.6%) | 28 (21.5%) | 1.32 | (0.69, 2.53) | 0.41 | 1.38 | (0.70, 2.75) | 0.36 | ns |
| CNS—no. (%) | 19 (24.1%) | 40 (30.8%) | 0.71 | (0.38, 1.35) | 0.30 | 0.81 | (0.41, 1.60) | 0.54 | ns |
| CRP > 45 mg/l—no. (%) | 47 (59.5%) | 72 (55.4%) | 1.18 | (0.67, 2.08) | 0.56 | 1.29 | (0.70, 2.38) | 0.41 | ns |
| Leukocytes < 4 or > 20 × 10^9/L—no. (%) | 51 (64.6%) | 66 (50.8%) | 1.77 | (0.99, 3.14) | 0.05 | 1.65 | (0.91, 3.02) | 0.10 | ns |
| Mechanical ventilation during LOS—no. (%) | 58 (73.4%) | 66 (46.2%) | 3.22 | (1.76, 5.91) | < 0.001 | 2.62 | (1.38, 4.96) | 0.003 | ns |
| Duration of mechanical ventilation during LOS, days —median (IQR) | 5.0 (2.3, 8.8) | 2.5 (1.7, 6.2) | 1.10 | (1.01, 1.19) | 0.023 | 1.09 | 1.00, 1.18 | 0.045 | ns |
| Cardiotonics during LOS—no. (%) | 22 (27.8%) | 23 (17.7%) | 1.80 | (0.92, 3.50) | 0.09 | 1.36 | (0.67, 2.77) | 0.40 | ns |
a adjusted for early-onset sepsis (EOS), gestational age (GA), and small for gestational age (SGA). LOS late-onset sepsis, CRP C-reactive protein, OR odds ratio, aOR adjusted odds ratio, CI confidence interval
Both sensitivity analyses show that that the need for and duration of mechanical ventilation were independently associated with an increased risk for developing BPD as well (Supplemental Table 2). In the culture-proven LOS analysis, this association was also found for abnormal leukocytes count.
Discussion
To our knowledge, this is the first cohort study investigating which clinical and biochemical characteristics of LOS modulate the development of BPD. Our results show that the need for and the duration of mechanical ventilation during LOS are independent risk factors for the development of BPD. Other clinical and biochemical factors of LOS did not influence the risk of BPD.
Consistent with previous studies, our study shows that infants with LOS have an increased risk of developing BPD compared to those without LOS. Zooming in on the infants with LOS, the only clinical parameter independently associated with the development of BPD was the need and duration of mechanical ventilation. Mechanical ventilation itself is an established risk factor for developing BPD [24, 25]. The same is true for systemic inflammation, which is often present during LOS. Our results suggest that the combination of these two risk factors augments the risk of BPD. Indeed, animal data and studies in neonatal and adult critical care suggest that the combination of systemic inflammation and invasive mechanical ventilation causes more ventilated-induced lung injury than either insult alone [26–28].
Most of the previous studies describing the association between LOS and the development of BPD only included infants with a positive blood culture and/or cerebrospinal fluid culture. However, obtaining an adequate sample for blood culture is challenging in (premature) neonates which results in a large proportion of false-negative blood cultures in clinical infectious infants [14–16]. Therefore, analyzing only culture-proven LOS episodes might introduce a selection bias. For this reason, we included infants with either culture-proven or clinical suspected episodes of sepsis. The fact that we still observed a higher risk to develop BPD makes selection bias in previous studies including only culture-proven sepsis less likely. Reassuringly, the results of the sensitivity analysis including only infants with culture-proven LOS yielded comparable results as previous reports in a similar population.
Previous studies have shown that LOS caused by gram-negative microorganisms is associated with a higher risk of death or BPD compared to those caused by gram positive microorganisms [9]. In this study, we found no modulating effect of microorganism on the risk to develop BPD in the group of infants with a culture-proven LOS. This discrepancy may be due to the relative small number of infants with a positive blood culture in our cohort compared to previous studies.
In contrast to our primary analysis, the sensitivity analysis in culture-proven LOS also showed an association between having leukopenia or leukocytosis and the risk of BPD. The association between leukocytosis and development of BPD has been previously reported in EOS, but not LOS [29]. The fact that we did not observe an association between leukocyte counts and BPD in the primary analysis may have been caused by inclusion of culture negative LOS episodes in this analysis. Some of these infants may have been classified as LOS based on clinical signs, while this was actually not the case (false positive episodes).
The sensitivity analysis including only those infants with one LOS episode showed the same association as found in the primary analysis. In previous studies, an additional risk to develop severe BPD after having repeated LOS episodes has been described [30]. However, this association is described in a specific group of infants receiving mechanical ventilation for 2 weeks. The effect of repeated LOS episodes on the development of BPD can be partly attributed to the duration of mechanical ventilation in their cohort.
The postnatal age of having an infectious episode is a critical determinant of the host immune response to sepsis [21]. Exposure to antimicrobials and stress is known to modify the subsequent immune response and may represent changes associated with trained innate immunity or adaptive immunity [21]. Given this change in immunity, the timing of LOS might alter the risk for long-term complications. This is the first study exploring this possible effect of the postnatal age of LOS onset on the development of BPD, reporting no indication that such a modulating effect exists.
This study has several strengths. It is the first study exploring the association between LOS-associated factors and the development of BPD. In addition, we included all infants treated with antibiotics for culture-proven or clinical suspected LOS episodes. This study also has limitations. First, the data was collected retrospectively, which might have affected the accuracy of the data. Second, since recruitment period of this study was 6 years, residual confounding might have impacted our study results although no major treatment policies were implemented in this period. Third, the data was collected from a single hospital, which might limit the generalizability of the study results. Fourth, in the analyses, we have excluded those infants who died before reaching the age of 36-weeks PMA. No accurate prediction model for the development of BPD is available yet [31]. Therefore, it is impossible to predict if the infants would have been diagnosed with BPD if they had survived. Including all these infants into the BPD group or, in the same line of reasoning, into the no BPD group might lead to an over- or underestimation of the results, respectively. For this reason, we analyzed the results in those infants surviving until 36-weeks PMA. Fifth, in our study, the definition of LOS was based on the duration of antibiotics, regardless of the blood culture. The duration of antibiotic treatment was (according to routine care) at the discretion of the treating clinician, which might be a source of misclassification. However, analyzing the whole group of infants with prolonged antibiotic treatment makes it representative with daily clinical care. One might even consider this inclusion criterion as a strength of this study. Furthermore, the results might be hampered by residual confounding given the potential clinical differences between the two populations, although the pulmonary condition prior to the LOS was not significant different. In addition, during the study period, pulmonary ultrasound was not used as diagnostic tool to rule out a ventilator acquired pneumonia [32]. Therefore, in this study, we cannot differentiate between pulmonary deterioration due to mechanical ventilation versus a ventilation acquired pneumonia secondary to this mechanical ventilation episode. Future prospective studies should incorporate this diagnostic tool in case of pulmonary deterioration after intubation for sepsis. Finally, in this study, no data on whether the infant was exclusively fed with mothers own milk was collected. Previous studies have shown that this factor is an important risk factor in the development of BPD [33, 34]. This covariate should be taken into consideration In future studies.
The results of this study might have implications for clinical practice. Anti-inflammatory agents like corticosteroids are preferably not administered to preterm infants during sepsis, because of the possible suppressive effect on the immune system. Given the results of this study showing the association between need for and duration of mechanical ventilation during a LOS episode and the increased BPD risk, future studies need to investigate if administration of corticosteroids to infants remaining on invasive mechanical ventilation and showing no improvement in lung condition for example 48 h after start of antibiotic treatment reduce the development of BPD in this high risk population.
In conclusion, the need for and the duration of mechanical ventilation during LOS are independently associated with an increased risk of developing BPD in preterm infants below 30 weeks of gestation with LOS.
Supplementary Information
(DOCX 13 kb)
(DOCX 17 kb)
Acknowledgments
Availability of data and material
Data available on request from the authors.
Code availability
Not applicable.
Abbreviations
- BPD
Bronchopulmonary dysplasia
- BW
Birthweight
- 95% CI
95% confidence interval
- CRP
c-reactive protein
- EOS
Early-onset sepsis
- GA
Gestational age
- IVH
Intraventricular hemorrhage
- IQR
Interquartile range
- LOS
Late-onset sepsis
- NEC
Necrotizing enterocolitis
- NICU
Neonatal intensive care unit
- OR
Odds ratio
- PDA
Persistent ductus arteriosus
- PMA
Postmenstrual age
- SD
Standard deviation
- SGA
Small for gestational age
Authors’ contributions
Ebrahimi: Conception and study design; collection, analysis and interpretation of data; writing first draft of the manuscript; drafting the manuscript for important intellectual content; decision to submit the paper for publication.
Romijn: Conception and study design; collection, analysis and interpretation of data; writing first draft of the manuscript; drafting the manuscript for important intellectual content; decision to submit the paper for publication.
Vliegenthart: Conception and study design; collection, analysis and interpretation of data; drafting the manuscript for important intellectual content; decision to submit the paper for publication.
Visser: Conception and study design; collection, drafting the manuscript for important intellectual content; decision to submit the paper for publication.
Van Kaam: Conception and study design; collection, drafting the manuscript for important intellectual content; decision to submit the paper for publication.
Onland: Conception and study design; collection, analysis and interpretation of data; drafting the manuscript for important intellectual content; decision to submit the paper for publication.
Declarations
Statement of ethics
This study was approved by the ethics committee AMC.
Consent to participate
For parental informed consent an opt-out procedure was followed.
Consent for publication
Not applicable.
Conflict of interest
The authors declare that they have no conflict of interest.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Melania P. Ebrahimi and Michelle Romijn contributed equally to this work.
Contributor Information
Melania E. Ebrahimi, Email: melaniaebrahimi@gmail.com
Michelle Romijn, Email: m.romijn1@amsterdamumc.nl.
Roos J. S. Vliegenthart, Email: r.j.vliegenthart@amc.uva.nl
Douwe H. Visser, Email: d.h.visser@amsterdamumc.nl
Anton H. van Kaam, Email: a.h.vankaam@amsterdamumc.nl
Wes Onland, Email: w.onland@amsterdamumc.nl.
References
- 1.Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23(2):167–172. doi: 10.1097/MOP.0b013e3283423e6b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, Laptook AR, Sánchez PJ, van Meurs K, Wyckoff M, Das A, Hale EC, Ball MB, Newman NS, Schibler K, Poindexter BB, Kennedy KA, Cotten CM, Watterberg KL, D'Angio CT, DeMauro S, Truog WE, Devaskar U, Higgins RD, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA. 2015;314(10):1039–1051. doi: 10.1001/jama.2015.10244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jobe AH. Mechanisms of lung injury and bronchopulmonary dysplasia. Am J Perinatol. 2016;33(11):1076–1078. doi: 10.1055/s-0036-1586107. [DOI] [PubMed] [Google Scholar]
- 4.Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170–177. doi: 10.1016/j.rmed.2017.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lapcharoensap W, Kan P, Powers RJ, Shaw GM, Stevenson DK, Gould JB, Wirtschafter DD, Lee HC. The relationship of nosocomial infection reduction to changes in neonatal intensive care unit rates of bronchopulmonary dysplasia. J Pediatr. 2017;180:105–109. doi: 10.1016/j.jpeds.2016.09.030. [DOI] [PubMed] [Google Scholar]
- 6.Bhandari V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):189–201. doi: 10.1002/bdra.23220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bose CL, Dammann CE, Laughon MM. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed. 2008;93(6):F455–F461. doi: 10.1136/adc.2007.121327. [DOI] [PubMed] [Google Scholar]
- 8.Speer CP. Pulmonary inflammation and bronchopulmonary dysplasia. J Perinatol. 2006;26(Suppl 1):S57–S62. doi: 10.1038/sj.jp.7211476. [DOI] [PubMed] [Google Scholar]
- 9.Shah J, Jefferies AL, Yoon EW, Lee SK, Shah PS. Canadian neonatal n. risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at < 32 weeks' gestation. Am J Perinatol. 2015;32(7):675–682. doi: 10.1055/s-0034-1393936. [DOI] [PubMed] [Google Scholar]
- 10.Eriksson L, Haglund B, Odlind V, Altman M, Ewald U, Kieler H. Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia. Acta Paediatr. 2015;104(3):259–263. doi: 10.1111/apa.12888. [DOI] [PubMed] [Google Scholar]
- 11.Klinger G, Levy I, Sirota L, Boyko V, Lerner-Geva L, Reichman B, in collaboration with the Israel Neonatal Network Outcome of early-onset sepsis in a national cohort of very low birth weight infants. Pediatrics. 2010;125(4):e736–e740. doi: 10.1542/peds.2009-2017. [DOI] [PubMed] [Google Scholar]
- 12.Hernandez-Ronquillo L, Tellez-Zenteno JF, Weder-Cisneros N, Salinas-Ramirez V, Zapata-Pallagi JA, da Silva O. Risk factors for the development of bronchopulmonary dysplasia: a case-control study. Arch Med Res. 2004;35(6):549–553. doi: 10.1016/j.arcmed.2004.07.001. [DOI] [PubMed] [Google Scholar]
- 13.Woynarowska M, Rutkowska M, Szamotulska K. Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates. Med Wieku Rozwoj. 2008;12(4 Pt 1):933–941. [PubMed] [Google Scholar]
- 14.Jiang S, Yang Z, Shan R, Zhang Y, Yan W, Yang Y, Shah PS, Lee SK, Cao Y. Neonatal outcomes following culture-negative late-onset sepsis among preterm infants. Pediatr Infect Dis J. 2020;39(3):232–238. doi: 10.1097/INF.0000000000002558. [DOI] [PubMed] [Google Scholar]
- 15.Das A, Shukla S, Rahman N, Gunzler D, Abughali N. Clinical indicators of late-onset sepsis workup in very low-birth-weight infants in the neonatal intensive care unit. Am J Perinatol. 2016;33(9):856–860. doi: 10.1055/s-0036-1579648. [DOI] [PubMed] [Google Scholar]
- 16.Wynn JL, Polin RA. Progress in the management of neonatal sepsis: the importance of a consensus definition. Pediatr Res. 2018;83(1-1):13–15. doi: 10.1038/pr.2017.224. [DOI] [PubMed] [Google Scholar]
- 17.Itoh K, Aihara H, Takada S, Nishino M, Lee Y, Negishi H, Itoh H. Clinicopathological differences between early-onset and late-onset sepsis and pneumonia in very low birth weight infants. Pediatr Pathol. 1990;10(5):757–768. doi: 10.3109/15513819009064710. [DOI] [PubMed] [Google Scholar]
- 18.Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM. New Dutch reference curves for birthweight by gestational age. Early Hum Dev. 2009;85(12):737–744. doi: 10.1016/j.earlhumdev.2009.09.008. [DOI] [PubMed] [Google Scholar]
- 19.Berkhout DJC, Klaassen P, Niemarkt HJ, de Boode WP, Cossey V, van Goudoever JB, Hulzebos CV, Andriessen P, van Kaam AH, Kramer BW, van Lingen RA, Vijlbrief DC, van Weissenbruch MM, Benninga M, de Boer NKH, de Meij TGJ. Risk Factors for necrotizing enterocolitis: a prospective multicenter case-control study. Neonatology. 2018;114(3):277–284. doi: 10.1159/000489677. [DOI] [PubMed] [Google Scholar]
- 20.Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723–1729. doi: 10.1164/ajrccm.163.7.2011060. [DOI] [PubMed] [Google Scholar]
- 21.Wynn JL, Guthrie SO, Wong HR, Lahni P, Ungaro R, Lopez MC, Baker HV, Moldawer LL. Postnatal age is a critical determinant of the neonatal host response to sepsis. Mol Med. 2015;21:496–504. doi: 10.2119/molmed.2015.00064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Vergnano S, Buttery J, Cailes B, Chandrasekaran R, Chiappini E, Clark E, Cutland C, de Andrade SD, Esteves-Jaramillo A, Guinazu JR, Jones C, Kampmann B, King J, Kochhar S, Macdonald N, Mangili A, de Menezes Martins R, Velasco Muñoz C, Padula M, Muñoz FM, Oleske J, Sanicas M, Schlaudecker E, Spiegel H, Subelj M, Sukumaran L, Tagbo BN, Top KA, Tran D, Heath PT, Brighton Collaboration Neonatal Infections Working Group Neonatal infections: case definition and guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2016;34(49):6038–6046. doi: 10.1016/j.vaccine.2016.03.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cortese F, Scicchitano P, Gesualdo M, Filaninno A, De Giorgi E, Schettini F, et al. Early and late infections in newborns: where do we stand? A review Pediatr Neonatol. 2016;57(4):265–273. doi: 10.1016/j.pedneo.2015.09.007. [DOI] [PubMed] [Google Scholar]
- 24.Mulder EE, Lopriore E, Rijken M, Walther FJ, te Pas AB. Changes in respiratory support of preterm infants in the last decade: are we improving? Neonatology. 2012;101(4):247–253. doi: 10.1159/000334591. [DOI] [PubMed] [Google Scholar]
- 25.Vendettuoli V, Bellu R, Zanini R, Mosca F, Gagliardi L, Italian NN. Changes in ventilator strategies and outcomes in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2014;99(4):F321–F324. doi: 10.1136/archdischild-2013-305165. [DOI] [PubMed] [Google Scholar]
- 26.Kroon AA, Wang J, Huang Z, Cao L, Kuliszewski M, Post M. Inflammatory response to oxygen and endotoxin in newborn rat lung ventilated with low tidal volume. Pediatr Res. 2010;68(1):63–69. doi: 10.1203/PDR.0b013e3181e17caa. [DOI] [PubMed] [Google Scholar]
- 27.Dell'Orto V, Raschetti R, Centorrino R, Montane A, Tissieres P, Yousef N, et al. Short- and long-term respiratory outcomes in neonates with ventilator-associated pneumonia. Pediatr Pulmonol. 2019;54(12):1982–1988. doi: 10.1002/ppul.24487. [DOI] [PubMed] [Google Scholar]
- 28.Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282(1):54–61. doi: 10.1001/jama.282.1.54. [DOI] [PubMed] [Google Scholar]
- 29.Zanardo V, Savio V, Giacomin C, Rinaldi A, Marzari F, Chiarelli S. Relationship between neonatal leukemoid reaction and bronchopulmonary dysplasia in low-birth-weight infants: a cross-sectional study. Am J Perinatol. 2002;19(7):379–386. doi: 10.1055/s-2002-35612. [DOI] [PubMed] [Google Scholar]
- 30.Jung E, Lee BS. Late-onset sepsis as a risk factor for bronchopulmonary dysplasia in extremely low birth weight infants: a nationwide cohort study. Sci Rep. 2019;9(1):15448. doi: 10.1038/s41598-019-51617-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Onland W, Debray TP, Laughon MM, Miedema M, Cools F, Askie LM, Asselin JM, Calvert SA, Courtney SE, Dani C, Durand DJ, Marlow N, Peacock JL, Pillow JJ, Soll RF, Thome UH, Truffert P, Schreiber MD, van Reempts P, Vendettuoli V, Vento G, van Kaam AH, Moons KG, Offringa M. Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study. BMC Pediatr. 2013;13:207. doi: 10.1186/1471-2431-13-207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Tusor N, De Cunto A, Basma Y, Klein JL, Meau-Petit V. Ventilator-associated pneumonia in neonates: the role of point of care lung ultrasound. Eur J Pediatr. 2021;180(1):137–146. doi: 10.1007/s00431-020-03710-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Miller J, Tonkin E, Damarell RA, McPhee AJ, Suganuma M, Suganuma H et al (2018) A systematic review and meta-analysis of human milk feeding and morbidity in very low birth weight infants. Nutrients 10(6) [DOI] [PMC free article] [PubMed]
- 34.Villamor-Martinez E, Pierro M, Cavallaro G, Mosca F, Kramer BW, Villamor E. Donor human milk protects against bronchopulmonary dysplasia: a systematic review and meta-analysis. Nutrients. 2018;10(2). [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
(DOCX 13 kb)
(DOCX 17 kb)
Data Availability Statement
Data available on request from the authors.

